Cargando…
Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country
BACKGROUND: The World Health Organization recommends establishing and implementing a national pharmaceutical policy (NPP) to guarantee effective and equitable access to medicines. Mexico has implemented several policy approaches to regulate the pharmaceutical sector, but it has no formal NPP. This a...
Autores principales: | Moye-Holz, Daniela, van Dijk, Jitse P, Reijneveld, Sijmen A., Hogerzeil, Hans V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540413/ https://www.ncbi.nlm.nih.gov/pubmed/28764738 http://dx.doi.org/10.1186/s12992-017-0281-1 |
Ejemplares similares
-
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
por: Moye-Holz, Daniela, et al.
Publicado: (2020) -
Access to innovative cancer medicines in a middle-income country - the case of Mexico
por: Moye-Holz, Daniela, et al.
Publicado: (2018) -
Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019) -
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America
por: Moye-Holz, Daniela, et al.
Publicado: (2021) -
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)